NDATOPICALLOTION
Approved
May 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID (hydrocortisone butyrate) is a topical corticosteroid lotion approved for atopic dermatitis. It works through anti-inflammatory, anti-pruritic, and vasoconstrictive mechanisms to reduce skin inflammation and itching. The drug is absorbed through the skin and metabolized hepatically like systemic corticosteroids.
LOE Approaching
Product is nearing loss of exclusivity with moderate competitive pressure (30); expect transition from growth-focused to defensive/niche positioning and potential team consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
LOCOID offers limited career growth opportunities given its LOE-approaching status and minimal linked job openings. Working on this product typically involves managing decline, defending against competitors, and transitioning to generic/OTC channels rather than building new markets.
Brand ManagerField Sales Representative
Worked on LOCOID at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.